Screener
TriSalus Life Sciences, Inc. TLSI Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034100
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Other expense, net | (76) | (251) |
| Income (loss) before income taxes | 1,543 | (10,370) |
| Income tax expense | (4) | (5) |
| Net income (loss) | $1,539 | $(10,375) |
| Undeclared dividends on Series A Preferred Stock | — | (712) |
| Net income (loss) attributable to common stockholders | $1,539 | $(11,087) |
| Basic earnings (loss) per share | $0.03 | $(0.39) |
| Diluted earnings (loss) per share | $0.03 | $(0.39) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is TriSalus Life Sciences, Inc.'s net income?
- TriSalus Life Sciences, Inc. (TLSI) reported net income of $1.54M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s net income changed year-over-year?
- TriSalus Life Sciences, Inc.'s net income increased by 114.8% year-over-year, from -$10.38M to $1.54M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s net income?
- Over 4 years (2021 to 2025), TriSalus Life Sciences, Inc.'s net income has grown at a 69.4% compound annual growth rate (CAGR), from $4.77M to -$39.23M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about TriSalus Life Sciences, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude